Skip to main content
. 2023 Apr 25;15(9):2073. doi: 10.3390/nu15092073

Table 1.

Baseline characteristics of the study group. Values are represented as median ± interquartile range (IQR, 25–75th percentile). NA means not applicable due to non-statistically significant values from Kruskal–Wallis test. BMI: body mass index; WHR: waist-to-hip ratio; AUC: area under the curve; HbA1c: hemoglobin A1c; HOMA-IR: Homeostatic Model Assessment for Insulin Resistance; ISI: Insulin Sensitivity Index; UCP: urinary C-peptide; UCR: urinary creatinine; UCPCR: urinary C-peptide-to-creatinine ratio. HbA1c: hemoglobin A1c [20–42 mmol/mol]; fasting blood glucose (70–100 mg/dL); fasting blood C-peptide [0.78–1.89 ng/mL]; fasting blood insulin (3–25 mU/L); blood creatinine (female: 0.50–0.90 mg/dL, male: 0.70–1.20 mg/dL). Numbers in bold are considered statistically significant (p value < 0.05).

Variables All
N = 447
Healthy
N = 317
PreDM
N = 87
T2DM
N = 43
p-Value Healthy vs. preDM
(p-adj.)
Healthy vs. T2DM
(p-adj.)
PreDM vs. T2DM
(p-adj.)
Age (years) 57
(51–63)
56
(51–62)
59
(53–66)
61
(58–67)
<0.001 0.021 0.002 0.728
BMI (kg/m2) 25.90
(23.67–29.05)
24.84
(22.75–27.50)
27.80
(25.60–30.80)
30.80
(26.10–33.90)
<0.001 <0.001 <0.001 0.111
Hip
circumference (cm)
99
(92–106)
96
(90–103)
103
(95–109)
108
(102–118)
<0.001 <0.001 <0.001 0.007
Waist
circumference (cm)
90
(80–100)
87
(77–95)
96
(90–105)
107
(97–116)
<0.001 <0.001 <0.001 0.035
WHR 0.92
(0.86–0.97)
0.90
(0.84–0.95)
0.96
(0.90–1.01)
0.98
(0.92–1.02)
<0.001 <0.001 <0.001 0.849
Weight (kg) 77
(66–86)
72
(63–83.50)
82
(74–88)
88
(80–103)
<0.001 <0.001 <0.001 0.124
Height (cm) 170
(164–178)
169
(164–176.50)
173
(165–179)
172
(165–178)
0.138 NA NA NA
Total lean mass (kg) 47.70
(40.75–57.50)
44.85
(39.85–56.27)
52.92
(43.77–57.93)
56.78
(45.29–62.98)
<0.001 <0.001 <0.001 0.504
Total fat mass (kg) 24.67
(19.48–31.60)
23.23
(18.32–28.88)
28.26
(22.15–36.25)
31.33
(27.07–37.66)
<0.001 <0.001 <0.001 0.190
Fasting blood glucose (mg/dL) 91
(86–100)
88
(84–93)
104
(100–108)
140
(123–164)
<0.001 <0.001 <0.001 0.029
AUC glucose 14,265
(12,180–17,805)
13,095
(11,610–15,008)
18,795
(16,815–20,730)
28,110
(24,660–34,470)
<0.001 <0.001 <0.001 0.001
HbA1c (mmol/mol) 37
(35–39)
36
(34–38)
39
(37–42)
52
(44–59)
<0.001 <0.001 <0.001 <0.001
Fasting blood C-peptide (ng/mL) 1.34
(1.02–1.98)
1.19
(0.93–1.58)
1.98
(1.44–2.58)
2.55
(1.77–3.35)
<0.001 <0.001 <0.001 0.142
1-h stimulated blood C-peptide
(ng/mL)
6.38
(5.00–8.46)
6.15
(4.59–7.98)
7.82
(6.20–10.34)
6.01
(4.54–8.15)
<0.001 <0.001 1.000 <0.001
2-h stimulated blood C-peptide (ng/mL) 5.56
(3.90–8.01)
4.77
(3.59–6.56)
7.94
(5.74–11.07)
8.14
(6.09–9.75)
<0.001 <0.001 <0.001 1.000
AUC C-peptide 621
(477–788)
576
(456–721)
787
(620–962)
686
(529–875)
<0.001 <0.001 0.020 0.114
Fasting blood insulin (mU/L) 9.20
(6.10–13.50)
7.90
(5.00–11.35)
11.90
(9.20–19.00)
16.10
(10.10–22.70)
<0.001 <0.001 <0.001 0.979
AUC insulin 5624
(3503–9272)
4968
(3303–8062)
7872
(4587–14,186)
6275
(3962–9389)
<0.001 <0.001 0.215 0.637
HOMA-IR 2.11
(1.35–3.32)
1.72
(1.10–2.50)
3.09
(2.28–4.81)
5.07
(3.60–9.22)
<0.001 <0.001 <0.001 0.047
HOMA-beta (%) 110.77
(76.91–161.05)
117
(82.87–163.39)
109.13
(84.65–178.05)
75.27
(40.91–115.41)
<0.001 1.000 0.001 0.002
ISI Stumvoll 0.09
(0.07–0.11)
0.10
(0.08–0.11)
0.08
(0.01–0.09)
0.06
(0.04–0.09)
<0.001 <0.001 <0.001 0.809
ISI Cederholm 50.78
(35.91–66.21)
57.08
(46.17–73.11)
34.87
(25.27–47.31)
20.28
(15.58–26.81)
<0.001 <0.001 <0.001 0.000
Matsuda index 5.06
(3.16–8.27)
6.17
(4.20–9.38)
3.09
(1.72–4.88)
2.18
(1.28–3.35)
<0.001 <0.001 <0.001 0.056
Blood creatinine (mg/dL) 0.86
(0.76–0.98)
0.84
(0.75–0.96)
0.93
(0.83–1.05)
0.86
(0.76–0.96)
<0.001 <0.001 1.000 0.133
UCP (nmol/L) 5.43
(2.98–9.73)
4.64
(2.60–8.00)
8.24
(4.73–11.85)
10.83
(8.31–15.43)
<0.001 <0.001 <0.001 0.071
UCR (mmol/L) 11.23
(6.72–15.38)
10.96
(6.10–15.38)
11.85
(7.69–16.00)
11.93
(8.49–16.09)
0.287 NA NA NA
UCPCR (nmol/mmol) 0.59
(0.33–0.93)
0.49
(0.30–0.81)
0.76
(0.46–1.10)
0.92
(0.59–1.80)
<0.001 <0.001 <0.001 0.269